Detalhe da pesquisa
1.
Low-Avidity CD4+ T Cell Responses to SARS-CoV-2 in Unexposed Individuals and Humans with Severe COVID-19.
Immunity
; 53(6): 1258-1271.e5, 2020 12 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-33296686
2.
PERcutaneous transhepatic CHOLangioscopy using a new single-operator short cholangioscope (PERCHOL): European feasibility study.
Dig Endosc
; 2023 Sep 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-37772447
3.
Therapeutic Interleukin-6 Trans-signaling Inhibition by Olamkicept (sgp130Fc) in Patients With Active Inflammatory Bowel Disease.
Gastroenterology
; 160(7): 2354-2366.e11, 2021 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-33667488
4.
Vedolizumab is associated with changes in innate rather than adaptive immunity in patients with inflammatory bowel disease.
Gut
; 68(1): 25-39, 2019 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-29730603
5.
Contrast enhanced endoscopic ultrasound detects early therapy response following anti-TNF-therapy in patients with ulcerative colitis.
J Crohns Colitis
; 2024 Mar 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-38457414
6.
Tryptophan degradation as a systems phenomenon in inflammation - an analysis across 13 chronic inflammatory diseases.
EBioMedicine
; 102: 105056, 2024 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-38471395
7.
Longitudinal multi-omics analysis identifies early blood-based predictors of anti-TNF therapy response in inflammatory bowel disease.
Genome Med
; 14(1): 110, 2022 09 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-36153599
8.
Combination therapy with vedolizumab and etanercept in a patient with pouchitis and spondylarthritis.
BMJ Open Gastroenterol
; 4(1): e000127, 2017.
Artigo
em Inglês
| MEDLINE | ID: mdl-28243458